high grade serous carcinoma
Showing 1 - 11 of 11
High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)
Recruiting
- High Grade Serous Carcinoma
- +2 more
- Olaparib tablet
- Navitoclax
-
Toronto, Ontario, Canada
- +2 more
Nov 28, 2022
BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)
Active, not recruiting
- BRCA1 Mutation
- +4 more
- Talazoparib Oral Capsule
-
Providence, Rhode Island
- +1 more
Nov 30, 2022
Investigate Adaptation and Evolution of Ovarian High-grade
Recruiting
- Ovarian Cancer
- +6 more
-
Bristol, United Kingdom
- +10 more
Sep 8, 2022
Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI
Not yet recruiting
- Cytoreductive Surgery
- +4 more
- PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
-
Boston, MassachusettsMassachusetts General Hospital
May 21, 2022
High Grade Serous Carcinoma Trial in Baltimore, Boston, Philadelphia (Olaparib Pill, AZD6738)
Recruiting
- High Grade Serous Carcinoma
- Olaparib Pill
- AZD6738
-
Baltimore, Maryland
- +2 more
Mar 4, 2022
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)
Terminated
- Epithelial Ovarian Cancer
- +4 more
-
Clovis, California
- +4 more
May 19, 2021
Compare Fallopian Tube Cells Collected by Cytuity With Removed
Completed
- Fallopian Tube Cancer
- +10 more
- Hysteroscopic cell sampling of the fallopian tube
-
San Diego, California
- +9 more
Dec 30, 2020
Ovarian Tumor Epithelial, High Grade Serous Carcinoma Trial in Seongnam Si (Pegylated liposomal doxorubicin plus Bortezomib)
Unknown status
- Ovarian Neoplasm Epithelial
- High Grade Serous Carcinoma
- Pegylated liposomal doxorubicin plus Bortezomib
-
Seongnam Si, Gyenggi DO, Korea, Republic ofSeoul National University Bundang Hospital
Jan 12, 2020
Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer
Unknown status
- High Grade Serous Carcinoma
- +4 more
- Sequencing of miRNA/lncRNA
-
Beijing, Beijing, ChinaLei Li
Nov 9, 2018